Archive
Faceted archive
267 documents matching
Undated
IN FORCE
68 Office Memorandum regarding Clarification of Comprehensive permission for products imported for overprinting/stickering/stamping as per Rule 104A of Drugs and Cosmetics Rules 1945 2025-May-26 438 K
IN FORCE
21 Carbimazole related agranulocytosis - Recommendations for the change in Prescribing Information Leaflets (PILs) 2026-Feb-17 518 KB
IN FORCE
19 Cancellation of Registration Certificates and lmport Registration Numbers for lmport of Cosmetics under the Cosmetics Rules, 2020- Regarding 2026-Feb-23 1314 KB
Kult App Pvt. Ltd.Kult E-Commerce Pvt. Ltd.Kutt App Pvt. Ltd.
IN FORCE
81 Launching of registration of Clinical Research Organisation applications through SUGAM Portal 2025-Mar-04 1867 KB
IN FORCE
43 Clarification for grant of permission for combipack product of lyophilised dry powder for injection /I.V infusion and diluents for reconstitution such as sterile water for injection / sodium Chlori
Clarification for grant of permission for combipack product of lyophilised dry powder for injection/ 1.V. infusion and diluents for reconstitution such as sterile water for injection [Sodium Chloride Injection
IN FORCE
24 CDSCO updated list of Laboratories for conducting Performance Evaluation of In-Vitro Diagnostic Medical Device 2026-Jan-19 608 KB
IN FORCE
113 Public Notice regarding Draft CDSCO Guidance for Industry Version 1.2 2024-Apr-10 1184 KB
IN FORCE
97 Baxter recall letter for Product Fibrin Sealant Kit Brand name Tisseel Lyo manufactured in Vienna Austria 2024-Sep-02 1508 KB
Baxter (India) Pyt. Ltd.Baxter Healthcare Corporation
IN FORCE
25 Disposal/Rejection of Long-Pending Applications on Sugam Portal Awaiting Query Response 2026-Jan-16 96 KB
IN FORCE
126 Appointment of First Appellate Authority & CPIO for the purpose of RTI (Technical) matters 2024-Jan-30 362 KB
IN FORCE
39 The list of standards published under Medical Equipment and Hospital Planning (MHD) of BIS as forwarded in 2025 2025-Oct-22 367 KB
IN FORCE
106 Withdrawal of indication for Olaparib Tablets 100mg and 150mg in the treatment of patient with gBRCA mutution and advanced ovarian cancer who have been treated with three or more prior lines of ch
Astrazeneca Pharma
IN FORCE
119 Manufacturing and marketing of unapproved drug Meropenem & Disodium EDTA for Injection 2024-Mar-08 383 KB
IN FORCE
135 Advisory to all manufacturer of cough syrup, various critical excipients 2023-Dec-05 418 KB
IN FORCE
73 Manufacturing and marketing of unapproved FDCs regarding 2025-Apr-11 223 KB
IN FORCE
181 Draft Guidance document on Guidance on Stability Studies of In-Vitro Diagnostic Medical Device (IVDMD) 2022-Jul-07 781 KB
IN FORCE
3 Strengthening Enforcement against Unauthorized Promotion and Distribution of GLP-1 Based Drugs 2026-May-18 75 KB
IN FORCE
180 Draft Guidance document on Guidance on Post-Market Surveillance of In-vitro Diagnostic Medical Device (IVDMD) 2022-Jul-07 594 KB
IN FORCE
131 Launching of National Single Window System (NSWS) Portal 2024-Jan-01 3669 KB
IN FORCE
179 Draft Guidance document on Overview on Performance Evaluation / External Evaluation of In vitro Diagnostic Medical Device (IVDMD) 2022-Jul-07 702 KB
IN FORCE
160 Details of rejected applications of Human Vaccine Manufacturers or Importers (Form CT-18/CT-21) 2022 2023-Mar-15 7 KB
IN FORCE
161 Details of rejected applications of Human Vaccine Manufacturers or Importers (Form CT-18/CT-21) 2021 2023-Mar-15 7 KB
IN FORCE
159 Details of rejected applications of Human Vaccine Manufacturers or Importers (Form CT-18/CT-21) 2020 2023-Mar-15 7 KB
IN FORCE
93 Submission of Clinical Trial Site Addition and change of Principal Investigator applications through SUGAM Portal 2024-Dec-30 70 KB
IN FORCE
89 Reconstitution of Internal Complaint Committee on Sexual Harassment Mumbai West Zone 2023-Oct-09 178 KB
IN FORCE
193 Availability of H1N1 Vaccine 2015-Feb-17 48kb
Serum Institute of India Ltd.Panacea Biotec Ltd.Bharat Biotech International. Ltd.
IN FORCE
169 NSQ Vi-Conjugate Typhoid Vaccine Batch No.TC010915 and Batch No. TC010417 of M/s Bio Med Pvt Ltd 2018-Mar-14 904kb
Bio Med Pvt. Ltd.Biomed Pvt. Ltd.
IN FORCE
67 Transfer order of CDSCO 2024 2024-May-14 1463 KB
IN FORCE
118 Transfer order for the year 2022-2023-4 2022-Sep-08 10353 KB
IN FORCE
124 Transfer order for the year 2022-2023-1 2022-Mar-10 1334 KB
IN FORCE
120 Transfer order for the year 2022-2023-2 2022-Jul-05 4607 KB
IN FORCE
173 Testing of Sample of Imported Vaccine 2017-Jun-05 1,420kb
IN FORCE
40 Suo-Moto Disclosure of Information Pertaining to CDSCO-HQ, Zonal, Sub-Zonal, Port Offices, and Laboratories for Third-Party Transparency Audit 2025-May-09 358 KB
IN FORCE
156 Information/Guidance regarding uploading of manufacturing site and formulations data on SUGAM Portal 2019-Nov-29 384KB
IN FORCE
76 Income Tax savings for FY- 2023-2024 2024-Feb-05 240 KB
IN FORCE
45 On line application for extension of time to comply with revised Sch M on ONDLS portal 2025-Mar-24 50 KB
IN FORCE
53 Reminder- Calculation of Income Tax Savings for the F.Y 24-25 2024-Nov-12 292 KB
IN FORCE
121 Office Memorandum regarding Sexual Harassment of Women at work Place constitution of a complaints committee 2022-Jun-17 856 KB
IN FORCE
131 Office order regarding leaves granted to Officers of CDSCO 2021-Aug-19 930 KB
IN FORCE
141 Office Meorandum regarding for pusuing higher qualification 2021-Mar-26 735 KB
IN FORCE
142 Office Memorandum regarding submission of immovable property retrun for the year 2020 2021-Jan-05 1811 KB
IN FORCE
104 Office Memorandam regarding appoint of CPIO for the purpose of RTI Technical matter 2023-Aug-01 313 KB
IN FORCE
138 Reconstituting of Internal Complaint Committee on sexual Harassment cases regarding 25 june 2021 2021-Jun-25 920 KB
IN FORCE
112 Office Memorandum regarding RTI Act 2005 for RDTL Chandigarh 2023-Mar-16 308 KB
IN FORCE
77 Office Order regarding senitization programme on PoSH (Prevention of Sexual Harassment) 2024-Jan-16 1033 KB
IN FORCE
135 Clarification if change in a) Polymorphs/crystalline/amorphous/solvates/hydrate etc (b) salt and (c) Derivative/analogue/ester etc of already approved active substance to be considered as new drug
IN FORCE
37 Appointment of CPIO for the purpose of RTI Technical Matters 2025-May-26 773 KB
IN FORCE
96 Reconstitution of Internal Complaint Committee on Sexual Harassment North Zone 2023-Sep-04 160 KB
IN FORCE
95 Reconstitution of Internal Complaint Committee on Sexual Harassment CDTL Kasauli 2023-Sep-04 591 KB
IN FORCE
94 Calculation of lncome Tax for the Financial Year 2O23-24 2023-Sep-11 392 KB
Page 4 / 6 ← Previous Next →